Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept in chronic urticaria
NCT00886795Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- May 2009
- Primary completion
- Mar 2013
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of abatacept in chronic urticaria (CU), sponsored by Johns Hopkins University. Primary endpoint: Number of Participants With Adverse Events at 6 months. Started May 2009; status: completed.
02
Drugs
abatacept
03
Conditions
chronic urticaria (CU)
Beyond the preview
Go deeper on NCT00886795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00886795.